Lably
Skip to content

Artesunate/mefloquine

Antimalarial drug

  • 1 min read
  • 1 chapter

Explore on Lably

ToursExplore Lably’s 3D tours

Side effects are similar to the medications being used separately. Use is recommended as it decreases the possibility of either medications being used alone. Dose forms appropriate for children are also available.

Artesunate/mefloquine came into commercial use in 2008. It is on the World Health Organization's List of Essential Medicines. It is approved for medical use in Brazil, India, and Malaysia. It is not commercially available in the United States.

Medical uses

Artesunate/mefloquine is a recommended treatment in Southeast Asia while in Africa artesunate/amodiaquine, artemether/lumefantrine, artesunate/sulfadoxine/pyrimethamine are often preferred.

More in Health

Food and Drug AdministrationFederal agency of the United States Department of Health and Human ServicesCenters for Disease Control and PreventionUnited States government public health agencyNauseaMedical symptom or conditionSeizurePeriod of symptoms due to excessive or synchronous neuronal brain activityVomitingExpulsion of stomach contents via the mouth or noseIntravenous therapyMedication administered into a vein